Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TCRX

Tscan Therapeutics Inc

May 07 • 01:29PM ET

1.20

-0.05 -4.40 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: LYEL FATE NKTX IMRX CGEN

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	15.89%	Shs Outstand	55.82M	Perf Week	3.02%
Market Cap	71.82M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	1.72%	Shs Float	50.55M	Perf Month	12.74%
Enterprise Value	36.30M	PEG	-	EPS next Q	-0.26	Inst Own	47.65%	Short Float	1.87%	Perf Quarter	31.26%
Income	-124.31M	P/S	7.86	EPS this Y	-2.00%	Inst Trans	-8.35%	Short Ratio	1.15	Perf Half Y	6.70%
Sales	9.14M	P/B	0.74	EPS next Y	5.29%	ROA	-46.50%	Short Interest	0.94M	Perf YTD	19.50%
Book/sh	1.61	P/C	0.56	EPS next 5Y	5.09%	ROE	-80.95%	52W High	2.57 -53.50%	Perf Year	-12.13%
Cash/sh	2.13	P/FCF	-	EPS past 3/5Y	28.66% 2.08%	ROIC	-68.29%	52W Low	0.88 35.43%	Perf 3Y	-50.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.63% 56.92%	Gross Margin	68.48%	Volatility	6.98% 8.67%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.97	EPS Y/Y TTM	12.67%	Oper. Margin	-1408.73%	ATR (14)	0.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.65	Sales Y/Y TTM	106.65%	Profit Margin	-1360.61%	RSI (14)	51.97	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	6.65	EPS Q/Q	16.19%	SMA20	0.19%	Beta	1.07	Target Price	6.00
Payout	-	Debt/Eq	0.95	Sales Q/Q	-54.77%	SMA50	7.00%	Rel Volume	1.13	Prev Close	1.25
Employees	142	LT Debt/Eq	0.88	Earnings	May 06 BMO	SMA200	-13.20%	Avg Volume	823.15K	Price	1.20
IPO	Jul 16, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-8.64% -60.72%	Trades		Volume	589,006	Change	-4.40%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)